The Asian Pediatric Hematology and Oncology Group (APHOG) and SIOP Asia invite you to the 5th APHOG Global Seminar. This year’s online session is about paediatric acute myeloid leukaemia (AML). Leading experts from Asia and the USA will present on low-dose induction chemotherapy, risk-adapted treatment where resources are limited, haploidentical transplantation and new targeted and cell therapies.
Date: Wednesday, 2 December 2026
Time:
- 06:00–08:00 EST (USA)
- 12:00–14:00 CET (Europe)
- 16:30–18:30 IST (India)
- 20:00–22:00 JST (Japan)
Format: Online webinar. Registration is free.
Programme
Opening Remarks
- Akira Nakagawara, Chair, Executive Council, APHOG
Moderators
- Dr Alice Yu (Taiwan)
- Dr Yongmin Tang (China)
Keynote Lectures
- “Low-Dose Induction Chemotherapy in Pediatric AML: Evidence from a Multicenter Randomized Trial and Future Directions”
Dr Li Gao (China) - “AML Risk Adapted Treatment in Resource Restricted Settings”
Dr Deepak Bansal (India) - “Advances in Myeloid Malignancies in Children: The Children’s Oncology Group Experience”
Dr Nobuko Hijiya (COG, USA) - “Haploidentical Transplantation of AML Followed by Donor-Derived NK Cell Therapy”
Dr Wing Leung (Singapore) - “Targeted and Cell Therapy for Pediatric AML: Before and After HSCT”
Dr Kirill Kirgizov (Russia)
Closing Summary
- Dr Rashmi Dalvi (India)
Organiser: Asian Pediatric Hematology and Oncology Group (APHOG)
Co-organisers: SIOP Asia (the Asian Continental Branch of SIOP) and NGO Magokoro Organization for Childhood Cancer (MOCC)
Paediatric oncologists, haematologists, transplant specialists, nurses, trainees and anyone else working in childhood cancer care are welcome.
Register here
You’ll get a confirmation email with the meeting details when you register.
